Comparison of Efficacy of Metformin Versus Pioglitazone in patients with Polycystic Ovarian Syndrome

被引:0
作者
Razzaq, Moona [1 ]
Wabasa, Nasma [2 ]
Aslam, Hira [3 ]
机构
[1] THQ Hosp, Jampur, Pakistan
[2] Bahawal Victoria Hosp, Dept Accid & Emergency, Bahawalpur, Pakistan
[3] BVH, Dept Med, Bahawalpur, Pakistan
来源
PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES | 2016年 / 10卷 / 04期
关键词
Polycystic; ovaries; ovulation; metformin; pioglitazone;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To compare the efficacy ofpioglitazone and metforminin women with polycystic ovary syndrome. Methods: This randomized trial was conducted at Department of Obstetrics & Gynecology, THQ Hospital Jampur from February 2016 to August 2016. Total 70 patients with polycystic ovary syndrome having 20-40 years of age with duration of disease > 3 month were recruited. Results: The mean age of women in group A was 29.97 +/- 5.28 years and in group B was 30.37 +/- 5.63 years. Mean duration of marriage in study group A was 4.74 +/- 2.40 years and in study group B was 4.91 +/- 2.25 years. The mean duration of disease in study group A was 3.69 +/- 1.59 years and in study group B was 3.94 +/- 1.84 years. Efficacy of Group A (metformin group) was 19 (54.29%) while in Group B (pioglitazone group) was 29 (82.86%) with p-value = 0.010. Conclusion: This studyconcluded that Pioglitazone is more effective as compare to metformin for ovulation induction in women with polycystic ovary syndrome.
引用
收藏
页码:1421 / 1424
页数:4
相关论文
共 19 条
[1]  
Amer SA., 2009, OBSTET GYNAECOL REPR, V19, P263
[2]   Metabolic and Hormonal Changes Induced by Pioglitazone in Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Clinical Trial [J].
Aroda, Vanita R. ;
Ciaraldi, Theodore P. ;
Burke, Paivi ;
Mudaliar, Sunder ;
Clopton, Paul ;
Phillips, Susan ;
Chang, R. Jeffrey ;
Henry, Robert R. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (02) :469-476
[3]   Treatment options for polycystic ovary syndrome [J].
Badawy, Ahmed ;
Elnashar, Abubaker .
INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2011, 3 :25-35
[4]   Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome [J].
Begum, Mosammat Rashida ;
Ferdous, Jannatul ;
Begum, Anowara ;
Quadir, Ehsan .
FERTILITY AND STERILITY, 2009, 92 (03) :853-857
[5]   Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome [J].
Brettenthaler, N ;
De Geyter, C ;
Huber, PR ;
Keller, U .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (08) :3835-3840
[6]   Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial [J].
Fux Otta, Carolina ;
Wior, Myriam ;
Iraci, Gabriel S. ;
Kaplan, Raquel ;
Torres, Diana ;
Isabel Gaido, Maria ;
Wyse, Eduardo P. .
GYNECOLOGICAL ENDOCRINOLOGY, 2010, 26 (03) :173-178
[7]   Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin [J].
Glueck, CJ ;
Moreira, A ;
Goldenberg, N ;
Sieve, L ;
Wang, P .
HUMAN REPRODUCTION, 2003, 18 (08) :1618-1625
[8]   Comparison of endocrine and ultrasound profiles during ovulation induction with clomiphene citrate and letrozole in ovulatory volunteer women [J].
Jirge, Padma Rekha ;
Patil, Rajendra S. .
FERTILITY AND STERILITY, 2010, 93 (01) :174-183
[9]   Metformin is a reasonable first-line treatment option for non-obese women with infertility related to anovulatory polycystic ovary syndrome - A meta-analysis of randomised trials [J].
Johnson, Neil .
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2011, 51 (02) :125-129
[10]   Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis [J].
Li, X-J ;
Yu, Y-X ;
Liu, C-Q ;
Zhang, W. ;
Zhang, H-J ;
Yan, B. ;
Wang, L-Y ;
Yang, S-Y ;
Zhang, S-H .
CLINICAL ENDOCRINOLOGY, 2011, 74 (03) :332-339